Can you combine ibuprofen with paracetamol? What the official leaflets say

Ibuprofen and paracetamol are two different substances with distinct mechanisms of action — and Poland has registered medicines that combine them in a single tablet. The official documentation of such a product (the SmPC) describes the dosing, limits and contraindications for this pairing. This article shows exactly what those documents say — with no medical advice of our own.

Important: This article is for information only and does not replace a consultation with a doctor or pharmacist. All doses and contraindications quoted here come from official leaflets and Summaries of Product Characteristics — before taking any medicine, read the leaflet in your own package, because dosing differs between products.

Can ibuprofen and paracetamol be taken together?

The shortest documented answer: this combination exists as a registered medicine. Poland’s official public Register of Medicinal Products, run within the national e-Health system, lists fixed-dose combination products containing both substances in one tablet. An over-the-counter example is Metafen: each tablet contains 200 mg of ibuprofen and 325 mg of paracetamol.

That matters, because registering a medicine in Poland requires a regulatory assessment of its documentation. Since a product combining ibuprofen with paracetamol passed that assessment and has an approved Summary of Product Characteristics (SmPC), the mere co-existence of these two substances in one regimen is not a “forbidden combination” — it is a documented product with its own rules of use.

Why does the combination make sense at all? The Metafen SmPC puts it plainly: ibuprofen and paracetamol are substances that differ in their site and mechanism of action. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) — it relieves pain, reduces fever and acts against inflammation. Paracetamol relieves pain and fever through a different mechanism, without a meaningful anti-inflammatory effect.

Mind the crucial caveat: “a registered combination product exists” is not the same as “anyone may freely stack one substance on top of the other”. The documentation specifies exact doses, exact contraindications and an exact duration of use — and that is what the rest of this article is about.

How does ibuprofen differ from paracetamol?

The table below gathers the basic differences as described by official leaflets and SmPCs of products available in Poland. Maximum doses refer to self-medication by adults according to OTC leaflets — your own leaflet may state different values, and that one is binding.

Feature	Ibuprofen	Paracetamol
Class	Non-steroidal anti-inflammatory drugs (NSAIDs)	Outside the NSAID class (analgesic and antipyretic)
Effects per leaflets	Pain relief, fever reduction, anti-inflammatory	Pain relief, fever reduction
Typical single adult dose (OTC leaflets)	200–400 mg	500–1000 mg
Maximum daily dose in self-medication (OTC leaflets)	Usually 1200 mg	Product-dependent, most often 3000–4000 mg
Administration	Leaflets recommend taking after a meal	Independent of meals (per most leaflets)
Main class contraindications (per SmPCs)	Active or past peptic ulcer disease, aspirin-induced asthma, severe kidney, liver or heart failure, third trimester of pregnancy	Severe liver failure, alcohol disease
What to watch with other medicines	Other NSAIDs (including acetylsalicylic acid), anticoagulants	Other products containing paracetamol (overdose risk)

Two things in this table deserve emphasis. First, the contraindications of the two substances barely overlap — which is why doctors and pharmacists treat them as different tools, not substitutes. Second, both substances appear in dozens of products under different brand names, so the real risk is not the combination itself but unknowingly doubling a dose.

What exactly does the combination product’s SmPC say?

The Summary of Product Characteristics of Metafen (200 mg ibuprofen + 325 mg paracetamol) is the most precise official document describing this combination on the Polish market. Here is what it documents:

• Dosing in adults: 1 or 2 tablets at a time; if necessary, the dose may be repeated up to three times a day; no more than 6 tablets per day (equivalent to 1200 mg of ibuprofen and 1950 mg of paracetamol).
• Adolescents over 12: 1 tablet at a time, up to three times a day, a maximum of 3 tablets per day.
• Duration: for short-term use; the smallest effective dose should be used for the shortest period necessary.
• The self-medication boundary: if symptoms persist or worsen, or the product is needed for longer than 3 days — the document refers you to a doctor.
• Administration: after a meal.
• The duplication warning: the SmPC explicitly instructs you to check that other medicines you take do not contain paracetamol, because taking several sources of paracetamol at once can lead to overdose. It warns analogously against combining with other NSAIDs, including acetylsalicylic acid at daily doses above 75 mg.

That last point is, in practice, the most important information in the whole document. Paracetamol is an ingredient of many popular “cold and flu” products, and ibuprofen appears in pain, fever and period-pain products under very different names. The Polish patient portal pacjent.gov.pl highlights exactly this scenario: medicines with different brand names but similar composition, taken at the same time.

If you want to quickly verify that your medicine cabinet holds no such “hidden duplicates”, you can check the composition of your medicines in the free mojApteczka interaction checker — no account needed. For the broader picture — what categories of interactions exist and how to read warnings — see our guide: Drug interactions — the complete guide.

When should you consult a doctor or pharmacist?

The list of contraindications in the combination product’s SmPC is long — one more argument for discussing painkiller combinations with a professional rather than deciding on the run. A consultation is particularly justified if any of the situations described in the documentation applies to you:

• Gastric or duodenal ulcer disease — active or past; the SmPC lists it among the contraindications.
• Bronchial asthma or hypersensitivity reactions after NSAIDs (so-called aspirin-induced asthma) — also a contraindication.
• Severe hypertension, heart disease, heart failure — the documentation excludes use in severe forms of these conditions.
• Kidney or liver impairment — severe failure is a contraindication; for milder impairment the SmPC recommends the lowest possible doses and monitoring.
• Pregnancy and breastfeeding — the Metafen SmPC lists them explicitly as contraindications for the combination product.
• Anticoagulants or clotting disorders — ibuprofen can prolong bleeding time.
• Age over 65 — according to the SmPC the risk of serious adverse reactions rises, particularly gastrointestinal ones.
• Regular alcohol consumption — alcohol disease is a contraindication; alcohol also increases the risk of liver damage with paracetamol.
• Pain or fever lasting longer than 3 days despite treatment — the self-medication boundary written into the documentation.

The patient portal pacjent.gov.pl also points to a phenomenon that particularly affects people taking many medicines at once: the more products, the easier it is for substances and side effects to overlap unintentionally. A pharmacist sees this problem daily and is the most accessible “consultation point” — you do not need an appointment to ask.

What about children?

Here the documentation is unambiguous, and it deserves respect. The SmPC of the combination product Metafen rules out use in children under 12 — the fixed-dose combination in this form is simply not registered for them.

For younger children only single-ingredient products are available (syrups, suppositories, suspensions), and their leaflets dose the substance by the child’s body weight, not by eyeballed age. Every product has its own dosing table — and that table applies, not a chart from an internet forum.

Can both substances be given to a child simultaneously or alternately? This article will not settle that, because it should not: that decision belongs to a paediatrician who knows the child, their weight and the course of the illness. If a fever does not respond to a medicine given according to the leaflet — that is a signal to contact a doctor, not to improvise schedules.

Where technology can help is organisation. The paediatric classification feature in mojApteczka labels the medicines in your cabinet by the age categories from official documentation — so in the middle of the night you can see faster which products are classified for children at all, and which are adult-only. It is an organisational tool, not an advisory one: the dose is always set by the leaflet and the paediatrician.

How do you avoid doubling a substance you cannot see at first glance?

The biggest documented risk around paracetamol and ibuprofen is not combining them with each other, but unknowingly taking the same substance from two sources. A real-life scenario: a “flu” tablet in the evening, a painkiller at night — both contain paracetamol, and the leaflet’s daily limit is exceeded without any ill intent.

What you can do systematically:

• Read the composition, not the brand name. The active substance is always listed on the package and in the leaflet.
• Keep one list of everything you take — including OTC products and supplements. On paper or in an app.
• Check every new medicine before first use. The free interaction checker compares it against the rest of your cabinet; the duplicate detection feature flags two different packages containing the same substance.
• Keep the official documents at hand. The leaflet and SmPC of every medicine registered in Poland are in the Register of Medicinal Products, and in the app — in the SPC documentation feature, also offline.

Summary: what the documents establish

Ibuprofen and paracetamol differ in mechanism of action and contraindication profile, and their combination exists in Poland as a registered fixed-dose product with its own precise documentation. That documentation also draws the boundaries: specific maximum doses, short-term use, no use in children under 12, and a long list of situations where treatment decisions belong to a doctor.

If you take away one thing from this read, let it be this: the leaflet of your specific product outranks any article — including this one. And as the medicines in your home cabinet multiply, mojApteczka helps you keep order: scan the packages, see compositions and expiry dates, and let the interaction checker flag duplicated substances. The Android app is available on Google Play.

Related mojApteczka features: Drug interactions · Duplicate detection · Paediatric classification

---

Questions about the medicines in your home cabinet? Write to us at kontakt@mojapteczka.pl — we are happy to help!